More groups are researching the effect of psychedelics on TBI. The post Doctors Look to Psychedelics to Address Concussion Crisis appeared first on Green...
The article Beckley Psytech Acquires Eleusis Therapeutics was originally published on Microdose. Beckley Psytech Strengthens Pipeline and Development...
Privately owned Empyrean Neuroscience, Inc. has launched with a $22 million Series A financing and a genetic engineering platform to advance a pipeline...
Privately-owned psychedelic medicine company Beckley Psytech Limited is buying Eleusis Therapeutics Limited in an all-stock transaction. By acquiring Eleusis,...
Psychedelic medicines company Beckley Psytech has reached an agreement to acquire its rival Eleusis Therapeutics, in alignment with The post Consolidation...
A prolific SPAC creator has found a business partner for its fifth blank check company with just four weeks to go before a business combination deadline....
Silo Pharma (NASDAQ: SILO) shares are catching a bid, moving 16% higher to reach $6.39 on Tuesday. The move isn’t surprising; SILO is attracting the...
The article News You Might Have Missed: Oct 17th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Psychedelic medicines make headlines for indications like PTSD, depression, and anxiety, but they’re being studied for a much broader range of conditions. The...
The article Palo Santo Closes $50 Million Psychedelic Investment Fund was originally published on Microdose. Palo Santo Closes $50 Million Psychedelic...